(Q37873013)

24 August 2017

title

Cost-effectiveness of screening for genital Chlamydia trachomatis (English)

1 reference

cost-effectiveness analysis

24 August 2017

main subject

Chlamydia trachomatis

0 references

1 reference

R Welte

1

1 reference

24 August 2017

H Jager

series ordinal

2

1 reference

24 August 2017

M J Postma

series ordinal

3

1 reference

24 August 2017

publication date

1 December 2001

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

24 August 2017

published in

1 reference

24 August 2017

volume

1

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

145-156

1 reference

Pathogenesis of Chlamydia induced pelvic inflammatory disease

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

The impact on accuracy and cost of ligase chain reaction testing by pooling urine specimens for the diagnosis of Chlamydia trachomatis infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Economic advantages of ligase chain reaction for diagnosis of genital Chlamydia trachomatis infection in GUM clinic attenders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Screening of Chlamydia trachomatis genital infection in a young Parisian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

Genome Sequence of an Obligate Intracellular Pathogen of Humans: Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.2.145

21 January 2018

Identifiers

DOI

10.1586/14737167.1.2.145

1 reference

24 August 2017

1 reference